This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally, this webinar covers many related processes sponsors will need to know, as they file for, conduct and close-out effective clinical studies in the U.S. and EU.
The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectation - Webinar by GlobalCompliancePanel
8 January 2014, Fremont, United States
Introduction
Venue
Online Training
Online Training, 161 Mission Falls Lane, Suite 216, Fremont, 94539, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Mr John Robinson
161 Mission Falls Lane, Suite 216, Fremont, 94539, United States of America
8004479407
Contact us by email
161 Mission Falls Lane, Suite 216, Fremont, 94539, United States of America
8004479407
Contact us by email
Related events
New Zealand Institute of 91AV Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
European Glycoscience Community Webinar Series
25 January 2024 15:00 - 19 December 2024 18:00
Search
Advertisement
Spotlight
Explore
Membership
